Home / Kexing Biopharm...

Kexing Biopharm Product List 2026

Article source：

Jun 09,2026

View： 80

LABEL:

Related News

Kexing Biopharm’s overseas commercial product, Albumin-bound Paclitaxel, has been approved for marketing in the Philippines.

Kexing Biopharm’s overseas commercial product, Albumin-bound Paclitaxel, has been approved for marketing in the Philippines.

Kexing Biopharm and Sinotherapeutics Reach Cooperation Agreement to Expand Overseas Markets for FDA-Approved Tofacitinib Product

Kexing Biopharm and Sinotherapeutics Reach Cooperation Agreement to Expand Overseas Markets for FDA-Approved Tofacitinib Product

Kexing Biopharm EU and US GMP Product List-20251023

Kexing Biopharm EU and US GMP Product List-20251023

Kexing Biopharm’s Overseas Products Bevacizumab and Sorafenib Approved for Marketing in Syria

Kexing Biopharm’s Overseas Products Bevacizumab and Sorafenib Approved for Marketing in Syria

Kexing Biopharm's Albumin-Bound Paclitaxel Product Approved in Multiple Regions

Kexing Biopharm's Albumin-Bound Paclitaxel Product Approved in Multiple Regions

Kexing Biopharm Honored with the "Most Valuable Brand Award" at the 2025 Cailian Press Eighth Investment Annual Conference